Disease assessment in systemic vasculitis. - Wikidata - awgldk - TriplyDB

Disease assessment in systemic vasculitis.

Disease assessment in systemic vasculitis.

http://www.wikidata.org/entity/Q38348251

about

Disease assessment in systemic vasculitis.

http://www.wikidata.org/entity/Q38348251

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Disease assessment in systemic vasculitis.

@en

type

label

Disease assessment in systemic vasculitis.

@en

prefLabel

Disease assessment in systemic vasculitis.

@en

P1433

Q38348251-346D70AC-3EF4-4D63-ABA2-9B82AB08D3B1

P1476

Q38348251-F2C14051-85E3-4A91-B0DC-B7CF5C37642A

P2860

Q38348251-0C7983B2-F831-450D-BBEE-FEEF65B49625

Q38348251-1743E714-1B20-47EA-9416-07BBFEA58144

Q38348251-1752EB80-4FD0-4B6B-82B5-55F32A33792C

Q38348251-185B7237-6E36-4849-8249-A6DA09D9D234

Q38348251-18DEA5C9-3113-4DF0-8F5D-A21BA84F6A1C

Q38348251-210585C0-E989-49AC-9166-B88CEE39FB85

Q38348251-26C4E8C6-A149-423D-BB34-2F4EE345A0C1

Q38348251-275CF077-CF33-4D36-B218-A3D4AA5C1D88

Q38348251-2C505307-C757-4FD7-BC8A-E1F5DB3849E2

Q38348251-32EFBAC3-AB58-4894-AF37-8A3F6E85E6B0

P304

Q38348251-6E201383-2CB3-4B87-B71F-02C01809C70A

P31

Q38348251-E03144DA-2D57-4D6A-886C-50F502F9A622

P356

Q38348251-B2240961-199C-4C31-9247-BE98C8209148

P407

Q38348251-F5FD8D7F-9B8D-4138-B1DB-E807691EC310

P478

Q38348251-4E1E1736-E70E-45C0-98B7-B4882A297010

P50

Q38348251-D2508DFE-406D-402D-BDE5-A169C636216B

P577

Q38348251-04B18D83-C023-44E5-BF68-9E7FF08AF69C

P698

Q38348251-141A15F2-99D4-4AB9-AEC2-7E64F4D30D40

P356

P1433

Nephrology Dialysis Transplantation

P1476

Disease assessment in systemic vasculitis.

@en

P2860

Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data.

Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis.

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.

P304

i76-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFV002

http://www.w3.org/2001/XMLSchema#string

P407

P478

30 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Raashid Ahmed Luqmani

P577

2015-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25662796

http://www.w3.org/2001/XMLSchema#string